D

Noveris Health Sciences Inc. NVRS

CNSX
Recommendation
Dividend Power Score
Day's Range
$0.07$0.08
Latest Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
EPS (TTM)
Access our Premium Ratings
Get Access

NVRS Rating

Reward
Risk

NVRS Rating Factors

Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index

NVRS Company Overview

Noveris Health Sciences Inc. is a publicly traded health sciences company associated with the development of biotechnology and wellness-related products, with historical activity tied to psychedelic medicine research, drug development, and health-focused consumer products. The company’s shares have traded on the OTC market under the ticker MYCOF, and public disclosures indicate that the business has undergone strategic and corporate transitions over time, including changes in branding and operational focus. Publicly available information suggests the company has explored opportunities in mental health therapeutics, pharmaceutical research, and related intellectual property development.

Available public filings and market disclosures indicate that the company has historically pursued commercialization opportunities connected to emerging health science sectors, particularly those involving novel therapeutic compounds and mental health treatment models. However, several operational and financial details are difficult to independently confirm through current public filings alone, and some historical disclosures appear tied to predecessor entities or prior corporate structures. Data inconclusive based on available public sources.

Data compiled by narrative technology. May contain errors.
Sector

NVRS Income Statement

Total Revenue (TTM)
--
EBITDA (TTM)
--
EBIT (TTM)
Net Income (TTM)

NVRS Balance Sheet

Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)

NVRS Cash Flow

Cash from Operations (TTM)
Cash from Investing (TTM)
--
Cash from Financing (TTM)
Net Change in Cash (TTM)

NVRS Price History

Loading...
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return

NVRS Valuation

Market Cap
Market Cap Rank
#17,154
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)

NVRS Dividends and Shares

Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--

NVRS Corporate Info

Phone Number
778 900 6877
Address
1075 West Georgia Street
Suite 1890
Vancouver, BC V6E 3C9
Country
Year Founded

NVRS Filings

Filing Date
Monday, August 31, 2026
Period Date
Tuesday, June 30, 2026
Next Filing
Week of Nov 16 and 20 (est)

NVRS Headlines

There are no news to display.